581P mRNA profiling as a biomarker of prognosis and response to first-line treatment in metastatic colorectal cancer: Discovery and validation of a gene expression signature in three randomized trials.

Authors :: Germani, M.M.
Heinemann, V.
Pietrantonio, F.
Fischer von W., L.
Na, I-K.
Hoppe, B.
Jarosch, A.
Lonardi, S.
Morano, F.
Medico, E.
Karthaus, M.
Fruehauf, S.
Graeven, U.
Decker, T.
Kaiser, F.
Stintzing, S.
Stahler, A.
Modest, D.P.
Source :: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS471-S471. 1p.
Publication Year :: 2024

Subjects :: *GENE expression
*COLORECTAL cancer
*METASTASIS
*BIOMARKERS
*MESSENGER RNA

Full Text Access

Tools